ENGEL: Expansion of global presence and records in customer-specific automation
By the end of March, internationally operating injection molding machine manufacturer ENGEL concluded the fiscal year 2023/24 with a total turnover of around 1.6 billion euros, indicating a minor downturn compared to the previous year. The company is meeting the mixed prospects with an expansion of its global presence while setting new benchmarks in order income for customer-specific automation solutions.
Adverse trends as a shortage of skilled workers and high production costs offer promising opportunities for customer-specific automation solutions – a segment that ENGEL has been dedicated to for many years, alongside manufacturing injection molding machines. Customers are increasingly inclined to automate as many process steps as possible directly via the machine, for instance, quality checks or packaging. Depending on the customer's preferences, the automation required integrates seamlessly with the machine to form a high-performance injection molding cell. "Most of the time we are fortunate to be involved in customer projects from the start," says Engleder. "This enables us to respond very specifically to requirements and tailor the optimal solution for our customer." While the standard segment remains stagnant, customised automation solutions are witnessing a significant upswing.
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance